1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Stoke Therapeutics, Inc.

Stoke Therapeutics, Inc.

STOK
Stoke Therapeutics, Inc.US flagNASDAQ Global Select
28.85
USD
+0.17
- -
1.80BMarket Cap

Income Statement (USD)

APIChat
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
12
9
37
184
+ Sales & Services Revenue
- -
- -
- -
- -
- -
12
9
37
184
- Cost of Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- -
-12
-9
-37
-184
- Operating Expenses
6
13
36
53
86
117
124
138
205
+ Selling, General & Admin
2
4
12
21
32
39
41
49
67
+ Research & Development
4
8
24
32
54
78
82
89
138
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
-6
-13
-36
-53
-86
-104
-115
-101
-21
- Non-Operating (Income) Loss
- -
- -
-3
-1
- -
-3
-10
-12
-14
+ Interest Expense, Net
- -
- -
-3
-1
- -
- -
- -
- -
- -
+ Interest Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Interest Income
- -
- -
3
1
- -
- -
- -
- -
- -
+ Other Non-Op (Income) Loss
- -
- -
- -
- -
- -
-3
-10
-12
-14
Pretax Income
-6
-13
-32
-52
-86
-101
-105
-89
-7
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-6
-13
-32
-52
-86
-101
-105
-89
-7
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-6
-13
-32
-52
-86
-101
-105
-89
-7
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-6
-13
-32
-52
-86
-101
-105
-89
-7
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-6
-13
-32
-52
-86
-101
-105
-89
-7
EBIT
-6
-13
-36
-53
-86
-104
-115
-101
-21
EBITDA
-5
-13
-35
-52
-85
-103
-112
-99
-19
EBITDA Margin (%)
- -
- -
- -
- -
- -
-828.78
-1,279.09
-271.36
-10.2
EBITA
-6
-13
-36
-53
-86
-104
-115
-101
-21
Gross Margin (%)
- -
- -
- -
- -
- -
100
100
100
100
Operating Margin (%)
- -
- -
- -
- -
- -
-841.24
-1,307.21
-277.31
-11.16
Profit Margin (%)
- -
- -
- -
- -
- -
-814.73
-1,192.47
-243.42
-3.73
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
1
1
2
2
2
2
Basic Weighted Avg Shares
13
24
18
33
37
39
44
54
- -
Basic EPS, GAAP
-0.43
-0.53
-1.8
-1.56
-2.34
-2.6
-2.38
-1.65
- -
Basic EPS from Cont Ops
-0.43
-0.53
-1.8
-1.56
-2.34
-2.6
-2.38
-1.65
- -
Diluted Weighted Avg Shares
13
24
18
33
37
39
44
54
- -
Diluted EPS, GAAP
-0.43
-0.53
-1.8
-1.56
-2.34
-2.6
-2.38
-1.65
- -
Diluted EPS from Cont Ops
-0.43
-0.53
-1.8
-1.56
-2.34
-2.6
-2.38
-1.65
- -

Balance Sheet (USD)

APIChat
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Total Current Assets
2
106
226
294
229
244
215
233
306
+ Cash, Cash Equivalents & STI
2
105
222
287
220
230
201
217
285
+ Cash & Cash Equivalents
2
105
222
287
145
114
191
128
84
+ ST Investments
- -
- -
- -
- -
75
116
10
89
200
+ Accounts & Notes Receiv
- -
- -
- -
- -
- -
1
- -
2
8
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
- -
2
6
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
1
- -
1
2
+ Inventories
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
1
3
7
9
14
14
13
13
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
1
1
3
4
10
12
13
39
113
+ Property, Plant & Equip, Net
- -
1
3
4
9
11
12
8
6
+ Property, Plant & Equip
1
2
3
5
12
16
19
17
16
- Accumulated Depreciation
- -
- -
1
2
3
4
7
9
10
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
- -
30
106
+ LT Investments
- -
- -
- -
- -
- -
- -
- -
30
106
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
- -
- -
1
1
1
1
- -
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
- -
1
1
1
1
- -
Total Assets
2
108
229
298
239
256
228
272
418
+ Payables & Accruals
- -
2
2
6
10
8
7
10
28
+ Accounts Payable
- -
1
1
1
2
1
2
2
5
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
- -
- -
1
4
7
7
5
8
23
+ ST Debt
- -
- -
- -
1
2
2
2
2
3
+ ST Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
1
2
2
2
2
3
+ Other ST Liabilities
3
1
2
5
6
21
22
27
27
+ Deferred Revenue
- -
- -
- -
- -
- -
15
15
19
12
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
3
1
2
5
6
6
6
8
15
Total Current Liabilities
4
2
4
11
17
31
31
40
58
+ LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Finance Leases
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Liabilities
- -
- -
- -
- -
4
40
38
2
8
+ Accrued Liabilities
- -
- -
- -
- -
- -
37
33
- -
7
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
- -
- -
- -
- -
4
3
5
2
1
Total Noncurrent Liabilities
- -
- -
- -
- -
4
40
38
2
8
Total Liabilities
4
2
4
12
21
71
69
43
66
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
12
131
282
396
414
483
561
720
850
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
12
131
282
396
414
483
561
720
850
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-13
-26
-58
-110
-196
-297
-402
-491
-498
+ Other Equity
- -
- -
- -
- -
- -
-1
- -
- -
1
Equity Before Minority Interest
-1
105
224
286
218
185
160
229
352
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
-1
105
224
286
218
185
160
229
352
Total Liabilities & Equity
2
108
229
298
239
256
228
272
418
Shares Outstanding
30
30
33
37
37
39
46
54
59
Number of Employees
- -
- -
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
1
2
2
2
2
3
Net Debt
-2
-105
-222
-287
-145
-114
-191
-128
-84
Net Debt to Equity
139.09
-100.32
-99.13
-100.43
-66.53
-61.43
-119.98
-55.88
-23.9
Tangible Common Equity Ratio
-52.97
97.7
98.11
96.02
91.17
72.19
69.88
84.34
84.23
Current Ratio
0.51
43.03
55.12
25.73
13.37
7.77
6.99
5.81
5.28
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChat
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
+ Net Income
-6
-13
-32
-52
-86
-101
-105
-89
-7
+ Depreciation & Amortization
- -
- -
- -
1
1
2
2
2
2
+ Non-Cash Items
- -
- -
2
7
18
25
27
28
34
+ Stock-Based Compensation
- -
- -
2
6
16
23
25
27
32
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
- -
- -
1
+ Other Non-Cash Adj
- -
- -
- -
1
1
2
2
1
1
+ Chg in Non-Cash Work Cap
- -
1
-1
2
- -
43
-6
-28
16
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
- -
- -
- -
-4
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
-1
-2
-3
-3
-5
1
-2
-1
+ Inc (Dec) in Accts Payable
- -
2
1
5
3
-4
-3
3
21
+ Inc (Dec) in Other
- -
- -
- -
- -
- -
52
-3
-29
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-5
-11
-31
-42
-67
-32
-81
-87
46
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
-1
-2
-1
-1
-4
-2
- -
-1
+ Acq of Fixed Prod Assets
- -
-1
-2
-1
-1
-4
-2
- -
-1
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
152
105
- -
45
52
129
88
+ Increase in Capital Stock
- -
- -
152
105
- -
45
52
129
88
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
-75
-42
108
-107
-186
+ Dec in LT Investment
- -
- -
- -
- -
12
159
108
60
137
+ Inc in LT Investment
- -
- -
- -
- -
-87
-201
- -
-167
-323
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
-1
-2
-1
-76
-46
106
-107
-187
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash From Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Repayments of Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Financing Activities
6
116
-2
3
1
1
1
2
10
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
6
116
150
108
1
46
53
131
97
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
- -
104
117
65
-142
-31
78
-63
-44
EBITDA
-5
-13
-35
-52
-85
-103
-112
-99
-19
EBITDA Margin (%)
- -
- -
- -
- -
- -
-828.78
-1,279.09
-271.36
-10.2
Free Cash Flow
-5
-12
-33
-43
-68
-36
-83
-87
45
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-12
-33
-43
-68
-36
-83
-87
45
Free Cash Flow per Basic Share
-0.43
-0.51
-1.82
-1.29
-1.85
-0.92
-1.88
-1.61
- -
Price/Free Cash Flow
- -
- -
-17.3
-50.37
-13.41
-12.87
-2.91
-6.88
- -
Cash Flow to Net Income
0.97
0.88
0.96
0.81
0.78
0.32
0.77
0.98
-6.62
Capital Expenditures
- -
-1
-2
-1
-1
-4
-2
- -
-1